Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress

Leukemia

Volumn 25, Issue 2, 2011, Pages 236-245

  Blalock, W L ^a   Bavelloni, A ^b   Piazzi, M ^a,c   Tagliavini, F ^a   Faenza, I ^a   Martelli, A M ^a,d   Follo, M Y ^a   Cocco, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d CNR   (Italy)

Author keywords

acute leukemia; mass spectrometry; nucleus; PKR; post translational modification

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE R;

ACUTE LEUKEMIA; ACUTE LEUKEMIA CELL; AMINO TERMINAL SEQUENCE; ARTICLE; BIOCHEMISTRY; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; CELL ISOLATION; CELL NUCLEUS; CELL STRESS; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 79751528879     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.264     Document Type: Article

References (38)

1. Roberts WK, Clemens MJ, Kerr IM. Interferon-induced inhibition of protein synthesis in L-cell extracts: an ATP-dependent step in the activation of an inhibitor by double-stranded RNA. Proc Natl Acad Sci USA 1976; 73: 3136-3140.
2. Williams BR. PKR; a sentinel kinase for cellular stress. Oncogene 1999; 18: 6112-6120.
3. Sadler AJ, Latchoumanin O, Hawkes D, Mak J, Williams BR. An antiviral response directed by PKR phosphorylation of the RNA helicase A. PLoS Pathog 2009; 5: e1000311.
4. Blalock WL, Bavelloni A, Piazzi M, Faenza I, Cocco L. A role for PKR in hematologic malignancies. J Cell Physiol 2010; 223: 572-591.
5. Yoon CH, Miah MA, Kim KP, Bae YS. New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses. EMBO Rep 2010; 11: 393-399.
6. Nakamura T, Furuhashi M, Li P, Cao H, Tuncman G, Sonenberg N et al. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 2010; 140: 338-348.
7. Mounir Z, Krishnamoorthy JL, Robertson GP, Scheuner D, Kaufman RJ, Georgescu MM et al. Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway. Sci Signal 2009; 2: ra85.
8. Blalock WL, Grimaldi C, Fala F, Follo M, Horn S, Basecke J et al. PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. J Cell Physiol 2009; 221: 232-241.
9. Follo MY, Finelli C, Mongiorgi S, Clissa C, Bosi C, Martinelli G et al. PKR is activated in MDS patients and its subcellular localization depends on disease severity. Leukemia 2008; 22: 2267-2269.
10. Kim SH, Gunnery S, Choe JK, Mathews MB. Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene 2002; 21: 8741-8748. (Pubitemid 36132395)
11. Kim SH, Forman AP, Mathews MB, Gunnery S. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 2000; 19: 3086-3094. (Pubitemid 30438465)
12. Basu S, Panayiotidis P, Hart SM, He LZ, Man A, Hoffbrand AV et al. Role of double-stranded RNA-activated protein kinase in human hematological malignancies. Cancer Res 1997; 57: 943-947. (Pubitemid 27098022)
13. Pataer A, Swisher SG, Roth JA, Logothetis CJ, Corn P. Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity. Cancer Biol Ther 2009; 8: 245-252.
14. Eley HL, McDonald PS, Russell ST, Tisdale MJ. Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition. Cancer Chemother Pharmacol 2009; 63: 651-659.
15. Jeffrey IW, Kadereit S, Meurs EF, Metzger T, Bachmann M, Schwemmle M et al. Nuclear localization of the interferoninducible protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res 1995; 218: 17-27.
16. Paquet C, Bose A, Polivka M, Peoc0h K, Brouland JP, Keohane C et al. Neuronal Phosphorylated RNA-Dependent Protein Kinase in Creutzfeldt-Jakob Disease. J Neuropathol Exp Neurol 2009; 68: 190-198.
17. Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F et al. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. Cancer Res 2007; 67: 4287-4294. (Pubitemid 46815076)
18. Nyakern M, Tazzari PL, Finelli C, Bosi C, Follo MY, Grafone T et al. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients. Leukemia 2006; 20: 230-238. (Pubitemid 43148660)
19. Zhang F, Romano PR, Nagamura-Inoue T, Tian B, Dever TE, Mathews MB et al. Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem 2001; 276: 24946-24958.
20. Romano PR, Garcia-Barrio MT, Zhang X, Wang Q, Taylor DR, Zhang F et al. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol 1998; 18: 2282-2297. (Pubitemid 28152676)
21. Su Q, Wang S, Baltzis D, Qu LK, Wong AH, Koromilas AE. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. Proc Natl Acad Sci USA 2006; 103: 63-68. (Pubitemid 43076105)
22. Dey M, Cao C, Dar AC, Tamura T, Ozato K, Sicheri F et al. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 2005; 122: 901-913. (Pubitemid 41345207)
23. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 2008; 105: 10762-10767.
24. Taylor DR, Tian B, Romano PR, Hinnebusch AG, Lai MM, Mathews MB. Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J Virol 2001; 75: 1265-1273. (Pubitemid 32094685)
25. Bennett RL, Blalock WL, Abtahi DM, Pan Y, Moyer SA, May WS. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood 2006; 108: 821-829. (Pubitemid 44154613)
26. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA et al. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 1998; 12: 1903-1929. (Pubitemid 28554464)
27. Liu TC, Lin PM, Chang JG, Lee JP, Chen TP, Lin SF. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. Am J Hematol 2000; 63: 170-175.
28. Dahia PL, Aguiar RC, Alberta J, Kum JB, Caron S, Sill H et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet 1999; 8: 185-193. (Pubitemid 29054260)
29. Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood 1998; 92: 3410-3415. (Pubitemid 28492352)
30. Li S, Koromilas AE. Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. J Biol Chem 2001; 276: 13881-13890.
31. Jammi NV, Whitby LR, Beal PA. Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun 2003; 308: 50-57. (Pubitemid 36904120)
32. Onuki R, Bando Y, Suyama E, Katayama T, Kawasaki H, Baba T et al. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer0s disease. Embo J 2004; 23: 959-968. (Pubitemid 38418762)
33. Zhang X, Li J, Sejas DP, Rathbun KR, Bagby GC, Pang Q. The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR). J Biol Chem 2004; 279: 43910-43919. (Pubitemid 39390699)
34. Von Holzen U, Pataer A, Raju U, Bocangel D, Vorburger SA, Liu Y et al. The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation. Clin Cancer Res 2007; 13: 6032-6039. (Pubitemid 350075059)
35. Planchon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci 2008; 121: 249-253. (Pubitemid 351356695)
36. Fan C, He L, Kapoor A, Rybak AP, De Melo J, Cutz JC et al. PTEN inhibits BMI1 function independently of its phosphatase activity. Mol Cancer 2009; 8: 98.
37. Garcia MA, Collado M, Munoz-Fontela C, Matheu A, Marcos-Villar L, Arroyo J et al. Antiviral action of the tumor suppressor ARF. Embo J 2006; 25: 4284-4292. (Pubitemid 44435226)
38. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 2005; 102: 10200-10205. (Pubitemid 41023349)